Everything you need to know about Cop28 as the summit begins

--:--
Every year the world’s leaders gather for the UN climate change conference, and after a year of record temperatures, this year’s summit has been called the most vital yet. As Cop28 begins in Dubai, Ian Sample hears from Guardian environment editor and resident Cop expert Fiona Harvey. She explains why this summit proved controversial before it even began, what the main talking points will be, and how countries can still collaborate to meet the goals set out in 2015’s Paris agreement. Help support our independent journalism at theguardian.com/sciencepod
29 Nov 2023 English United Kingdom Science · Nature

Other recent episodes

Nitazenes and xylazine: what’s behind the rise of dangerous synthetic drugs?

Social affairs correspondent Robert Booth tells Madeleine Finlay why a class of synthetic opioids called nitazenes, first developed in the 1950s, is leading to a worrying number of fatal overdoses in the UK. And she hears from toxicology and addiction specialist Dr Joseph D’Orazio about a tranquilliser called xylazine that…
19 Feb 16 min

What apes can tell us about the origins of teasing

We all know people who find it hilarious to prod and poke, pinch and tickle, all in the name of fun. But are humans the only ones who like to tease each other? Or are other animals in on the act? Ian Sample talks to Prof Erica Cartmill about her…
14 Feb 15 min

Retinol, acids and serums: why are children obsessed with anti-ageing products?

Last month the British Association of Dermatologists warned that children as young as eight years old were using potentially damaging anti-ageing skin care products. Madeleine Finlay speaks to consultant dermatologist Dr Emma Wedgeworth about where this trend has come from, what damage these products might be causing to young skin…
12 Feb 15 min

Why are we still waiting for a male contraceptive pill?

Despite research into a male contraceptive pill starting around the same time as its female counterpart, no product has ever made it to market. But that could soon change, with a new non-hormonal male pill entering human trials in the UK late last year. Ian Sample speaks to bioethicist Prof…
7 Feb 17 min